Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc KHTRF


Primary Symbol: T.GUD

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Post by Chianchinon Aug 15, 2023 7:02pm
144 Views
Post# 35590047

How much did GUD pay for GBT Argentina's Operation.

How much did GUD pay for GBT Argentina's Operation.Now is is worth 10% of what GUD originaly paid. 
Argentina faces mounting pressure to devalue its currency again as its government struggles to avoid economic collapse ahead of elections in October, following the shock presidential primary victory of a radical rightwing candidate. The black-market dollar, which is a staple of Argentine life, has jumped to almost double the new official exchange rate after an 18 per cent devaluation of the peso following the primary win by outsider candidate Javier Milei. At the current black market rate of about 705 pesos a dollar, the largest denomination peso banknote in circulation is worth less than $3, forcing Argentines to carry around large wads of notes. The official exchange rate stands at 361 pesos to the dollar.
<< Previous
Bullboard Posts
Next >>